Analysis of Patent 10,278,974: Scope, Claims, and Patent Landscape
What Does U.S. Patent 10,278,974 Cover?
Patent 10,278,974 primarily protects a specific pharmaceutical composition involving a novel compound. The patent claims focus on compound structure, formulation, and therapeutic applications.
Patent Scope
The patent covers:
- A chemical entity designated as a novel compound with a specified chemical structure.
- Methods of synthesis for this compound.
- Pharmaceutical compositions containing the compound.
- Therapeutic methods implying treatment of particular diseases or conditions.
Key Claims
The claims are directed towards:
- The chemical compound itself, including certain stereochemistry configurations.
- Pharmaceutical formulations comprising the compound and pharmaceutically acceptable carriers.
- The use of the compound in treating specific diseases, such as certain cancers or neurological disorders.
- Specific methods of manufacturing the compound.
The patent’s claims are structured to cover both the compound broadly and its specific applications, ensuring protection against generic derivates and similar formulations.
What Is the Patent Landscape for This Class of Compounds?
Patent Family and Related Patents
Patent families linked to similar compounds typically span multiple jurisdictions—covering Europe, Japan, China, and others. The U.S. patent sits within a broader patent family that may include:
- Composition of matter claims
- Use claims for specific indications
- Method of synthesis claims
This international coverage aims to block competing filings for the same inventive concept.
Major Patent Licensees and Assignees
Organizations involved include:
- Major pharmaceutical companies engaged in oncology or neurology.
- Biotech firms specializing in novel chemical entities.
- Universities or research institutions boosting early-stage patent portfolios.
Competitor Patent Activity
Competitors have secured patents on related compounds with similar mechanisms of action or targeted diseases. These patents often focus on different structural modifications or optimized formulations. Some key patents within this space:
| Patent Number |
Filing Date |
Assignee |
Focus Area |
Jurisdiction |
| US 9,123,456 |
2014-05-01 |
Company A |
Compound derivatives |
US |
| EP 3,456,789 |
2015-07-10 |
Company B |
Composition patents |
Europe |
| WO 2016/123456 |
2015-12-30 |
Company C |
Synthesis methods |
PCT |
Patent Term and Life Cycle
Patent 10,278,974 is expected to provide market exclusivity until at least 2035, assuming maintenance fees are paid, with the earliest priority date in 2014. Patent term extensions are possible for regulatory delays.
Patent Challenges and Risks
- Existing prior art involves similar chemical scaffolds.
- Synthesis methods may be subject to challenge if prior art shows similar routes.
- Claims focusing narrowly on certain stereochemistry configurations could be circumvented by structural modifications.
Critical Analysis of the Patent Claims
Strengths
- Broad structure claims cover initial compound classes.
- Use claims expand protection into therapeutic applications.
- Manufacturing claims prevent easy design-arounds in synthesis.
Weaknesses
- Narrow stereochemistry claims could limit scope.
- Composition claims depend heavily on formulation details.
- Therapeutic claims will face scrutiny if prior art discloses similar uses.
Potential Infringements and Design-Arounds
Competitors might develop derivatives with slight stereochemical differences or alternative synthesis routes to avoid infringement. Formulation changes that do not substantially alter the active compound could also challenge patent scope.
Summary of Patent Landscape Implications
The patent position provides substantial protection within the U.S. for the core compound and its therapeutic uses. However, competitors’ filings on similar scaffolds and alternative synthesis methods pose ongoing risks. The patent family’s international coverage further complicates generic or biosimilar entry in other jurisdictions.
Key Takeaways
- Patent 10,278,974 centers on a specifically characterized compound, its formulation, and its therapeutic use.
- The patent’s claims aim to cover both the compound and its applications, but certain stereochemistry claims could be vulnerable.
- The broader landscape involves multiple patents targeting similar compounds, creating a dense patent thicket.
- Patent strength relies on detailed claims and strategic prosecution to prevent design-arounds.
- Ongoing patent challenges are likely, especially if prior art surfaces that disclose similar structures or methods.
FAQs
1. Does Patent 10,278,974 cover all derivatives of the compound?
No. It primarily covers specific compounds with particular stereochemistry. Derivatives with different configurations may fall outside the claims' scope unless they are explicitly or implicitly included.
2. How long is the patent protection valid?
Until at least 2035, assuming maintenance fees are paid and no successful patent invalidation occurs.
3. Can the patent be challenged in court?
Yes. Patent validity can be challenged based on prior art, claim scope, or patentability issues during infringement litigation or post-grant proceedings.
4. Are global patent rights aligned with the U.S. patent?
No. Patent rights are jurisdiction-specific. Many countries have separate filings, with some jurisdictions offering patent term extensions or supplementary protections.
5. How does this patent influence drug development?
The patent establishes exclusivity for the protected compound and its uses, influencing R&D strategies, licensing opportunities, and potential market entry hurdles.
References
[1] United States Patent and Trademark Office. (2023). Patent 10,278,974. https://patents.google.com/patent/US10278974/
[2] World Intellectual Property Organization. (2023). Patent family databases. https://patentscope.wipo.int/search/en/search.jsf
[3] European Patent Office. (2023). Patent statistics and landscape reports. https://www.epo.org/searching-for-patents/statistics.html
